Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer

Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer

Background: Recombinant von Willebrand factor (rVWF), which was licensed in the United States in 2015, has the multimeric distribution of freshly secreted VWF with ultralarge (UL) and high molecular weight multimers (HMWM) from endothelial cells and megakaryocytes since it has never been exposed to...

Full description

Bibliographic Details
Main Authors:	Isabell Pekrul, Thorsten Kragh, Peter L Turecek, Aaron R Novack, Helmut W Ott, Michael Spannagl
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-02-01
Series:	Platelets
Subjects:	pfa platelet function analyzer recombinant von willebrand factor rvwf ultralarge and high molecular weight multimers
Online Access:	http://dx.doi.org/10.1080/09537104.2017.1420153

Similar Items

A novel approach to laboratory assessment and reporting of platelet von Willebrand factor
by: Thorsten Kragh, et al.
Published: (2022-02-01)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
by: Martin Büchsel, et al.
Published: (2023-01-01)

Establishing reference intervals for von Willebrand factor multimers
by: Pikta Marika, et al.
Published: (2022-01-01)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
by: Inge Vangenechten, et al.
Published: (2020-08-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

Enfermedad de von Willebrand adquirida. Aspectos generales Acquired von Willebrand’s disease. General aspects
by: Alina Díaz Concepción
Published: (2004-04-01)

The Prevalence of von Willebrand Disease and Significance of in Vitro Bleeding Time (PFA-100) in von Willebrand Disease Screening in the İzmir Region
by: Fatih Şap, et al.
Published: (2013-03-01)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
by: Bauer A, et al.
Published: (2023-06-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

VON WILLEBRAND DISEASE
by: Valeriu Popescu, et al.
Published: (2009-11-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
by: Marie‐Daniéla Dubois, et al.
Published: (2022-05-01)

Usefulness of multiple electrode aggregometry as a screening tool for bleeding disorders in a pediatric hospital
by: Thorsten Haas, et al.
Published: (2019-05-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)

Von Willebrand Disease in the elderly: clinical perspectives
by: Chapin J
Published: (2018-08-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2020-10-01)

Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)
by: Ivonne Wieland, et al.
Published: (2022-11-01)

Multiple Sclerosis Diagnosed in a Woman With Von-Willebrand Disease: A Case Report
by: Mohsen Farjoud Kouhanjani, et al.
Published: (2022-07-01)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)

Pseudo (Platelet-type) von Willebrand disease in pregnancy: a case report
by: Grover Neetu, et al.
Published: (2013-01-01)

Platelets compensate for poor thrombin generation in type 3 von Willebrand disease
by: Timea Szanto, et al.
Published: (2020-01-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)

Impact of Von Willebrand Factor on Bacterial Pathogenesis
by: Michael Steinert, et al.
Published: (2020-09-01)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
by: Maurice Swinkels, et al.
Published: (2021-08-01)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01)

Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
by: Antoine Rauch, et al.
Published: (2019-02-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
by: Hiroaki Yaoi, et al.
Published: (2023-12-01)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
by: Michelle Sholzberg, et al.
Published: (2021-07-01)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
by: Alessandra Casonato, et al.
Published: (2021-08-01)

Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease
by: Muhammad Asif Naveed, et al.
Published: (2022-05-01)

Diagnosis of von Willebrand disease during the management of deep neck abscess: A case report
by: Akihisa Tanaka, et al.
Published: (2022-12-01)